The study authors observed that the number of intra-tumoral TIGIT positive cells outnumbered CD8+ T cells, indicating that other immune cells (including NK cells) might be suppressed within the tumor microenvironment via this checkpoint. The gene discussed is CD8A; the disease is neoplasm.